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Cancer is a devastating disease that touches the lives of millions of people around the world. After 17 
many years of work by thousands of scientists and clinicians around the globe the overall survival of 18 
patients who acquire certain types of cancer has been dramatically improved. However, the overall 19 
survival rates for some forms of cancer remain stubbornly low. It is therefore imperative to devise 20 
novel avenues of research from which to derive new opportunities for drug development and 21 
identification of new tools for early diagnosis and disease monitoring.  22 
 23 
One such emerging area of intensive research is the concept of the tumour microenvironment. 24 
Cancer cells do not grow as a homogenous mass, existing in isolation from other cell types, but 25 
rather in collaboration with other cells in the environment of the tumour. These stromal cells, which 26 
under normal conditions support the function of healthy tissues, surround and perfuse the tumour 27 
mass and interact with cancer cells. This communication in the tumour microenvironment often 28 
leads to the corruption of the stromal cells, allowing them to inappropriately stimulate and support 29 
the growth of the tumour. Understanding the signalling mechanisms between the different cells of 30 
the tumour microenvironment holds promise as the key to developing new therapeutics that could 31 
ďloĐk the ĐaŶĐer’s support ŵeĐhaŶisŵ.  32 
 33 
Extracellular vesicles (EVs) are small lipid-bound vesicles released by cells into the extracellular 34 
space. Initially thought of as a biological curiosity, they are now known to be important messengers 35 
mediating the dialogue between cells. The cargo they carry can either be internalised and utilised by 36 
recipient cells or interact with receptors at the plasma membrane leading to intracellular signalling. 37 
One cell can therefore affect the phenotype of another cell via the transfer of EVs with specific types 38 
of cargo such as RNA or protein. EVs have been shown to have a number of roles, including in 39 
regulating the immune system, angiogenesis and stress responses. Importantly, their dysregulation 40 
can have pathological effects and their abnormal function has been implicated in cancer.  41 
 42 
The combination of these two novel fields has led researchers to study the role of EVs in the tumour 43 
microenvironment. This convergence of disciplines has led to exciting new insight into the way in 44 
which tumours are affected by EV-mediated communication between cancer and stromal cells. Like 45 
any new field with promise it needs to be nurtured and supported. For this reason the Royal Society 46 
held a “ĐieŶĐe MeetiŶg iŶ JaŶuarǇ ϮϬϭ7 eŶtitled ͞EǆtraĐellular VesiĐles aŶd the Tuŵour 47 
MiĐroeŶviroŶŵeŶt͟.  This exciting meeting was well attended and led to this special edition of the 48 
Philosophical Transactions B. In this special edition we start with a more detailed introduction to the 49 
topic and the meeting. The rest of the special edition, which includes reviews, opinion pieces and 50 
research articles, describes various aspects of EV biology in the tumour microenvironment. The 51 
review articles and opinion pieces cover a range of aspects, including EV heterogeneity, the role of 52 
lipids and EVs in tumour progression, EVs in cell senescence, cell death and immune function, and 53 
the way in which miRNAs carried by EVs can acts as ligands to trigger the activation of receptor 54 
proteins. The research articles describe how EVs released by ovarian cancer cells treated with 55 
chemotherapy can affect other cells in the vicinity leading to tumour progression, and how EVs 56 
released by glioblastoma cells can alter human astrocytes leading them to be pro-tumorigenic.  57 
 58 
The exciting field of EVs in the tumour microenvironment is growing rapidly. Greater understanding 59 
could lead to novel therapeutics to tackle cancer, and new tools to aid diagnosis and prognosis. We 60 
hope that readers will enjoy this special edition of Philosophical Transactions B, which sheds light on 61 
this expanding field.  62 
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